145 related articles for article (PubMed ID: 25098403)
1. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit.
Hacker SM; Mortensen F; Scheffner M; Marx A
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10247-50. PubMed ID: 25098403
[TBL] [Abstract][Full Text] [Related]
2. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
3. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
[TBL] [Abstract][Full Text] [Related]
4. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
5. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
Zawacka-Pankau J; Podhajska AJ
Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
7. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
Shi Y; Zou M; Farid NR; Paterson MC
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):443-8. PubMed ID: 11085938
[TBL] [Abstract][Full Text] [Related]
8. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein.
Asensio AC; Rodríguez-Ferrer CR; Oaknin S; Rotllán P
Biochimie; 2006 May; 88(5):461-71. PubMed ID: 16359767
[TBL] [Abstract][Full Text] [Related]
11. Small-Molecule Inhibitors of the Tumor Suppressor Fhit.
Lange S; Hacker SM; Schmid P; Scheffner M; Marx A
Chembiochem; 2017 Sep; 18(17):1707-1711. PubMed ID: 28643453
[TBL] [Abstract][Full Text] [Related]
12. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
Askari MD; Vo-Dinh T
Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.
Weiske J; Albring KF; Huber O
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20344-9. PubMed ID: 18077326
[TBL] [Abstract][Full Text] [Related]
15. Activation of Gαq subunits up-regulates the expression of the tumor suppressor Fhit.
Zuo H; Chan AS; Ammer H; Wong YH
Cell Signal; 2013 Dec; 25(12):2440-52. PubMed ID: 23993961
[TBL] [Abstract][Full Text] [Related]
16. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
18. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
19. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.
Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K
Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.
Garrison PN; Robinson AK; Pekarsky Y; Croce CM; Barnes LD
Biochemistry; 2005 Apr; 44(16):6286-92. PubMed ID: 15835917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
